Wednesday, January 03, 2018 11:36:22 AM
Stereotyping the ticker TXTM as if nothing ever positive could happen for it in the future because of its past is not the correct way of thought. That is absolutely not true and is not correct. That is not a factual thought.
Things that was previously considered negative with no hope have changed for the better to be positive with hope very often with many stocks within the market. I can tell you many success stories that happened because of change.
TXTM can be clearly considered and compared to GW Pharmaceuticals (GWPH:NASDAQ) because of the simple logic explained courtesy of sharky, C.R.T., and myself from the posts below:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137373591
Marijuana License that we are going after - there are only a few issued around the world and the principal player that hold this license is GW Pharmaceuticals.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135276841
Listen to this video skip to 2:30 and listen to TXTM CEO as he states the license that we are going after - there are only a few issued around the world and the principal player that hold this license is GW PHARMACEUTICALS YES YOU HEARD THAT RIGHT ..... GW PHARMA
Currently trades at $109 per share
$$$ TXTM
https://m.youtube.com/watch?v=YbpvGdM1c0o
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135290285
TXTM*Cannabis Biosciences & GW Pharmaceuticals Comparison...
Thanks for posting this. First, I think investors need to know that the government of South Africa (SA) submitted a Bill to become part of law that was first published in Mar 2017. The Bill clearly outlines what you have to do to pursue obtaining a Marijuana License in South Africa (SA). The Bill allows for the government of South Africa (SA) to have the authority to approve who's authorized to grow cannabis and conduct cannabis research for the purpose of medicines.
The post below explains the importance of Oct 13, 2017 and how TXTM is positioned to obtain approval of the marijuana License they are seeking for the country of South Africa (SA):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134835060
TXTM has brought Plandai Biotechnology SA and Cannabis Bioscience, Inc. under them as wholly-owned subsidiaries. Both will be instrumental in the growth of TXTM as Cannabis Bioscience, Inc. has been created after the GW Pharmaceuticals business mode.
Now all should go to the TXTM video below and skip to 2:30 and listen to the TXTM CEO who states that... the Marijuana License that we are going after - there are only a few issued around the world and the principal player that hold this license is GW Pharmaceuticals. As indicated within the post below,
For inquiring minds... GW Pharmaceuticals trades on the NASDAQ at $110.00+ per share and is a $2.8 Billioncompany:
https://finance.yahoo.com/quote/GWPH/
https://www.gwpharm.com/
v/r
Sterling
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
Recent TXTM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 10:01:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 01:45:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:12:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:12:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:11:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:11:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 03:11:42 PM
- ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases • GlobeNewswire Inc. • 03/13/2026 03:29:44 PM
- Protext Mobility, Inc. (OTC: TXTM) is thrilled to share a transformative update, advancing uplisting readiness with a preliminary Deloitte engagement • GlobeNewswire Inc. • 01/20/2026 05:30:21 PM
- Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update • GlobeNewswire Inc. • 11/19/2025 06:05:51 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation • GlobeNewswire Inc. • 11/17/2025 07:41:34 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces Launch Phase of Its Next-Generation Investor Relations Suite and Corporate Website Modernization — Ushering in a New Era of Transparency, Innovation, and Shareholder Confidence • GlobeNewswire Inc. • 11/07/2025 07:13:39 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation • GlobeNewswire Inc. • 10/31/2025 04:19:52 PM
- Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration • GlobeNewswire Inc. • 10/27/2025 05:21:34 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement • GlobeNewswire Inc. • 10/17/2025 01:43:14 PM
- Protext Mobility, Inc. (OTC: TXTM) Announces New Member of Its Advisory Board • GlobeNewswire Inc. • 10/08/2025 03:58:18 PM
- ProText Mobility, Inc. Provides Shareholder Update • GlobeNewswire Inc. • 09/12/2025 01:44:35 PM
